Dark Forest Capital Management’s Harmony Biosciences HRMY Stock Holding History

Dark Forest Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,928	Closed	-$2.06M	–	945
2025 Q4	$2.06M	Sell	54,928 -2,978	-5%	-$97.9K	0.09%	377
2025 Q3	$1.6M	Sell	57,906 -27,442	-32%	-$945K	0.06%	561
2025 Q2	$2.7M	Buy	85,348 +7,772	+10%	+$250K	0.11%	314
2025 Q1	$2.57M	Buy	77,576 +62,001	+398%	+$2.22M	0.12%	290
2024 Q4	$536K	Buy	+15,575	New	+$535K	0.08%	407
2023 Q4	–	Sell	-42,952	Closed	-$1.41M	–	762
2023 Q3	$1.41M	Buy	+42,952	New	+$1.49M	0.11%	273
2023 Q2	–	Sell	-2,312	Closed	-$75.5K	–	1199
2023 Q1	$75.5K	Buy	2,312 +2,197	+1,910%	+$100K	0.02%	746
2022 Q4	$6.34K	Buy	+115	New	+$6.32K	﹤0.01%	821

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Dark Forest Capital Management's HRMY Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 54,928 shares — an estimated $2.06M sold.

Dark Forest Capital Management first reported a position in HRMY in Q4 2022 and held it in 8 quarters. The position peaked at $2.7M in Q2 2025. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

Dark Forest Capital Management reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 54,928 Harmony Biosciences shares in Q1 2026, an estimated $2.06M.
Dark Forest Capital Management first reported a position in Harmony Biosciences in Q4 2022 and held it in 8 quarters.
Dark Forest Capital Management's Harmony Biosciences position peaked at $2.7M in Q2 2025.
311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.